cals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs for weight management, cardiovascular disease, inflammation and other disorders. BELVIQ®
(lorcaserin HCl), Arena's internally discovered drug, was approved by the US Food and Drug Administration in June 2012, and is under review for regulatory approval in additional territories. Arena's US operations are located in San Diego, California, and its operations outside of the United States, including its commercial manufacturing facility, are located in Zofingen, Switzerland. For more information, visit Arena's website at www.arenapharm.com
Arena Pharmaceuticals® and Arena® are registered service marks of Arena Pharmaceuticals, Inc. BELVIQ® is a registered trademark of Arena Pharmaceuticals GmbH.
About Ildong Pharmaceutical Co., Ltd.Ildong Pharmaceutical Co., Ltd., based in Seoul, Korea, is a leading Korean company focused on the development, manufacturing and marketing of pharmaceuticals and OTC products with sales of $294 million in 2011. Ildong, founded in 1941, is known to have leading expertise in various therapeutic categories, including antibiotics, gastrointestinal, anti-diabetics, cardiovascular and oncology. For more information, visit Ildong's website at www.ildong.com.
Forward-Looking StatementsCertain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the development, therapeutic indication and use, safety, efficacy, mechanism of action, regulatory approval and commercialization of temanogrel; the potential of temanogrel and other products in the same category, including as compared to other therapies; rights, obligations, expectations and future activities related to the co-dev
Page: 1 2 3 4 5 Related medicine technology :1
|SOURCE Arena Pharmaceuticals, Inc.|
Copyright©2012 PR Newswire.
All rights reserved
. Arena Pharmaceuticals to Webcast Live Presentation at the Piper Jaffray 24th Annual Healthcare Conference2
. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences3
. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results4
. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Tuesday, November 65
. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference6
. Arena Pharmaceuticals to Present at Upcoming Investor Conferences7
. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments8
. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 99
. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control10
. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference11
. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs